Disease/Infection News

RSS

Nosopharm reports findings on Odilorhabdins that has potential to combat antibiotic resistance

Nosopharm, a specialist in the research and development of new anti-infective drugs, announces today its in vitro and in vivo findings for a novel antibacterial class, Odilorhabdins, which has the potential to combat antibiotic resistance.

4 Sep 2014

Bristol-Myers Squibb launches Daklinza in the UK for treatment of chronic hepatitis C

Bristol-Myers Squibb today announced the launch of Daklinza▼ (daclatasvir) in the UK, a new medicine for the treatment of adult patients with chronic hepatitis C. Daclatasvir, a treatment that works across multiple hepatitis C genotypes, will allow up to 90% of UK patients the option of a potentially curative oral treatment regimen that does not include interferon, a standard of care commonly associated with sustained flu-like side effects.

4 Sep 2014

F2G begins F901318 Phase I clinical study for treatment of aspergillus infections

F2G Limited, the antifungal research and development company today announced a major milestone in the development of its novel IV/ oral systemic antifungal (F901318) with the commencement of a Phase I clinical study.

4 Sep 2014

Legatum Foundation donates $150,000 to Ebola Crisis Fund

The Legatum Foundation, the development arm of the Legatum Group, today announced a donation of $150,000 to the Ebola Crisis Fund, a fund established to help prevent the spread of the deadly Ebola virus in West Africa.

3 Sep 2014

New regulatory component in infectious bacterium helps explain ability to survive in human body

The discovery of a new regulatory component in an infectious bacterium could aid efforts to explain its ability to survive in the human body, report microbiologists at The University of Texas Health Science Center at Houston (UTHealth) and University of Maryland, College Park, in the journal Science.

3 Sep 2014

Scientists make important breakthrough in fight against debilitating autoimmune diseases

Scientists have made an important breakthrough in the fight against debilitating autoimmune diseases such as multiple sclerosis by revealing how to stop cells attacking healthy body tissue.

3 Sep 2014

Researchers discover pattern of infection of bacterium responsible for causing severe lung infections

Researchers at the University of Liverpool's Institute of Infection and Global Health have discovered the pattern of infection of the bacterium responsible for causing severe lung infections in people with cystic fibrosis.

3 Sep 2014

Biochemists discover proteins that could lead to better treatments for life-threatening infections

Two Kansas State University biochemists have discovered a family of proteins that could lead to better treatments for Staphylococcus aureus, a pathogenic bacterium that can cause more than 60,000 potentially life-threatening infections each year.

3 Sep 2014

Study suggests phages are sophisticated bacterial predators and can prevent infections

In the battle between our immune systems and cholera bacteria, humans may have an unknown ally in bacteria-killing viruses known as phages.

3 Sep 2014

CleveXel Pharma, Guilin Pharmaceutical partner to speed up development of anti-malarial products

CleveXel Pharma today announces that the company has entered into a new partnering agreement with Guilin Pharmaceutical, a Chinese company located in Shanghai, regarding the development of two new products.

3 Sep 2014

Synthetic announces positive results from final preclinical toxicology study of SYN-004

Synthetic Biologics, Inc., a developer of novel anti-infective biologic and drug candidates targeting specific pathogens that cause serious infections and diseases, announced today positive results from its final preclinical toxicology study of SYN-004.

2 Sep 2014

Soligenix announces promising preliminary results from study on ricin toxin vaccine

Soligenix, Inc., a clinical stage biopharmaceutical company focused on developing products to treat serious inflammatory diseases where there remains an unmet medical need, as well as developing several biodefense vaccines and therapeutics, announced today promising preliminary results from a preclinical study with its ricin toxin vaccine RiVax™, in a non-human primate (NHP) lethal aerosol exposure model.

2 Sep 2014

Cepheid releases Xpert Flu/RSV XC for accurate determination of Flu A, Flu B and RSV infection

Cepheid announced today the release of Xpert® Flu/RSV XC, an on-demand molecular test for rapid, accurate and reliable determination of Flu A, Flu B, and differentiation of RSV infection.

2 Sep 2014

New genetic barcode helps identify different types of tuberculosis

Doctors and researchers will be able to easily identify different types of tuberculosis (TB) thanks to a new genetic barcode devised by scientists from the London School of Hygiene & Tropical Medicine.

2 Sep 2014

Researchers develop new test to identify sickle cell disease in minutes

Within minutes after birth, every child in the U.S. undergoes a battery of tests designed to diagnose a host of conditions, including sickle cell disease. Thousands of children born in the developing world, however, aren't so lucky, meaning many suffer and die from the disease each year.

2 Sep 2014

Researchers come up with new technique to diagnose malaria

Over the past several decades, malaria diagnosis has changed very little. After taking a blood sample from a patient, a technician smears the blood across a glass slide, stains it with a special dye, and looks under a microscope for the Plasmodium parasite, which causes the disease.

1 Sep 2014

University of Leicester research sniffs out smell of disease in feces

A fast-sensitive "electronic-nose" for sniffing the highly infectious bacteria C. diff, that causes diarrhoea, temperature and stomach cramps, has been developed by a team at the University of Leicester.

1 Sep 2014

New blood test provides fast, accurate diagnosis of tuberculosis in children

A new blood test provides a fast and accurate tool to diagnose tuberculosis in children, a new proof-of-concept study shows. The newly developed test (TAM-TB assay) is the first reliable immunodiagnostic assay to detect active tuberculosis in children.

1 Sep 2014

Wockhardt receives coveted QIDP status from FDA for WCK 771 and WCK 2349 drugs

Wockhardt Limited today announces a major boost to the New Drug Discovery program in Anti-Infective research when two of its drugs, WCK 771 and WCK 2349, received the coveted Qualified Infectious Disease Product (QIDP) status from U.S. Food & Drug Administration.

1 Sep 2014

Researchers identify how Ebola virus dodges the body's antiviral defenses

Researchers at the Washington University School of Medicine have identified one way the Ebola virus dodges the body's antiviral defenses, providing important insight that could lead to new therapies, in research results published in the journal Cell Host & Microbe.

30 Aug 2014

Disease/Infection News

Nosopharm reports findings on Odilorhabdins that has potential to combat antibiotic resistance

Bristol-Myers Squibb launches Daklinza in the UK for treatment of chronic hepatitis C

F2G begins F901318 Phase I clinical study for treatment of aspergillus infections

Legatum Foundation donates $150,000 to Ebola Crisis Fund

New regulatory component in infectious bacterium helps explain ability to survive in human body

Scientists make important breakthrough in fight against debilitating autoimmune diseases

Researchers discover pattern of infection of bacterium responsible for causing severe lung infections

Biochemists discover proteins that could lead to better treatments for life-threatening infections

Study suggests phages are sophisticated bacterial predators and can prevent infections

CleveXel Pharma, Guilin Pharmaceutical partner to speed up development of anti-malarial products

Synthetic announces positive results from final preclinical toxicology study of SYN-004

Soligenix announces promising preliminary results from study on ricin toxin vaccine

Cepheid releases Xpert Flu/RSV XC for accurate determination of Flu A, Flu B and RSV infection

New genetic barcode helps identify different types of tuberculosis

Researchers develop new test to identify sickle cell disease in minutes

Researchers come up with new technique to diagnose malaria

University of Leicester research sniffs out smell of disease in feces

New blood test provides fast, accurate diagnosis of tuberculosis in children

Wockhardt receives coveted QIDP status from FDA for WCK 771 and WCK 2349 drugs

Researchers identify how Ebola virus dodges the body's antiviral defenses

How agentic AI is reshaping laboratory workflows

Fourier 80: bringing benchtop NMR systems to the laboratory

How industrial hygiene flow calibration supports defensible exposure data

Latest News